Should Pfizer’s AstraZeneca Bid Worry the U.K.?

Should Pfizer’s AstraZeneca Bid Worry the U.K.? Play

May 5 (Bloomberg) -- Mark Schoenebaum, head of healthcare research at ISI Group, examines Pfizer’s bid for AstraZeneca as the U.K. government calls for an inquiry into the potential deal on Bloomberg Television’s “Bloomberg Surveillance.”

blog comments powered by Disqus